Yonaxis I.P. Law Group Logo
Category: patent | Yonaxis I.P. Law Group

Category: "patent"

of 29

Fed Circuit Watch: Dropped Priority Claim Invalidates Patent

On April 19, 2018, the Court of Appeals for the Federal Circuit handed down Droplets, Inc. v. E\Trade Bank*, in a case dealing with the formal issue of preparing a proper claim of priority in the...

Fed Circuit Watch: Swearing Behind Must be Supported by Sufficient Evidence

On April 17, 2018, the Court of Appeals for the Federal Circuit held in Apator Miitors ApS v. Kamstrup A/S, that in order for a patent assignee to swear behind a reference by antedating its own...

SCOTUS Watch: IPRs Do Not Violate Article III or Seventh Amendment

Article III of the U.S. Constitution states: The judicial power of the United States, shall be vested in one Supreme Court, and in such inferior courts as the Congress may from time to time ordain...

Fed Circuit Watch: Plain Claim Language Not Narrowed Unless Patentee Explicitly Disclaims Scope

An interesting study in organic chemistry appeared at the Federal Circuit. On April 16, 2018, a Fed Circuit panel in Sumitomo Dainippon Pharma Co., Ltd. v. Emcure Pharm. Ltd., held that plain claim...

Fed Circuit Watch: Personalized Medicine Method Claim Passes Alice Test for Subject Matter Eligibility

This case, Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals Int’l Ltd., arrived to the appeals court through an unusual, but not uncommon, route: a 35 U.S.C. §271(e)(4)(A) infringement...

Fed Circuit Watch: Knowles Déjà Vu as PTAB Not (Necessarily) Bound to Prior Court Claim Construction

In a case of déjà vu, the Court of Appeals for the Federal Circuit handed down Knowles Electronics LLC v. Iancu, on April 6, 2018. This case bears striking resemblance to an earlier-issued case this...

Fed Circuit Watch: No Overlap Required for Prima Facie Obviousness Between Claimed & Prior Art Ranges

On March 27, 2018, the Court of Appeals for the Federal Circuit ruled in In re Brandt, which is just another case in a long line of cases dealing with ranges and obviousness under 35 U.S.C. §103....

CannabIP: U.S. Patent No. 9,889,100 B2

|

U.S. Patent No. 9,889,100 B2 issued on February 13, 2018, for “Cannabidiol for Treatment of Severe and Refractory Graft-Versus-Host Disease.” The inventor is Moshe Yeshurun, and the...

Fed Circuit Watch: Common Sense Cannot Replace Evidentiary Support

On March 23, 2018, the Court of Appeals for the Federal Circuit handed down DSS Techs. Mgmt., Inc. v. Apple Inc., reversing two IPR decisions in Apple’s favor on a DSS-owned patent which the PTAB...

of 29